Literature DB >> 12670691

Activation of the complement cascade by Bordetella pertussis.

Michael G Barnes1, Alison A Weiss.   

Abstract

Bordetella pertussis must survive the defenses of the human respiratory tract including the complement system. The BrkA (Bordetella resistance to killing) protein prevents killing by the antibody-dependent classical pathway. In this study, the ability of B. pertussis to activate the human complement cascade by other pathways was examined. B. pertussis was not killed in serum depleted of C2, however serum depleted for factor B killed B. pertussis as efficiently as intact serum, suggesting complement activation occurred exclusively by the classical pathway. B. pertussis was not killed by serum depleted of antibody, suggesting the bacteria fail to activate the antibody-independent branches of the classical pathway, including the mannose binding lectin pathway. Mutants lacking the terminal trisaccharide of lipopolysaccharide retained the complement-resistant phenotype, suggesting this structure does not influence activation of complement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670691     DOI: 10.1016/S0378-1097(03)00132-0

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  10 in total

1.  Acellular pertussis vaccines and complement killing of Bordetella pertussis.

Authors:  Alison A Weiss; Angela K Patton; Scott H Millen; Swei-Ju Chang; Joel I Ward; David I Bernstein
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

2.  Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Kari Torkildsen Brandsdal; Bjørn Peter Berdal; Erja M Aleksandersen; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2007-05-16

3.  The Bordetella pertussis Bps polysaccharide enhances lung colonization by conferring protection from complement-mediated killing.

Authors:  Tridib Ganguly; John B Johnson; Nancy D Kock; Griffith D Parks; Rajendar Deora
Journal:  Cell Microbiol       Date:  2014-02-13       Impact factor: 3.715

4.  An Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii.

Authors:  Meng-Hooi Shu; NorAziyah MatRahim; NurAsyura NorAmdan; Sui-Ping Pang; Sharina H Hashim; Wai-Hong Phoon; Sazaly AbuBakar
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

5.  Acquisition of C1 inhibitor by Bordetella pertussis virulence associated gene 8 results in C2 and C4 consumption away from the bacterial surface.

Authors:  Elise S Hovingh; Bryan van den Broek; Betsy Kuipers; Elena Pinelli; Suzan H M Rooijakkers; Ilse Jongerius
Journal:  PLoS Pathog       Date:  2017-07-24       Impact factor: 6.823

6.  Bordetella pertussis isolates vary in their interactions with human complement components.

Authors:  Charlotte Brookes; Irene Freire-Martin; Breeze Cavell; Frances Alexander; Stephen Taylor; Ruby Persaud; Norman Fry; Andrew Preston; Dimitri Diavatopoulos; Andrew Gorringe
Journal:  Emerg Microbes Infect       Date:  2018-05-09       Impact factor: 7.163

7.  Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients.

Authors:  Elise S Hovingh; Betsy Kuipers; Axel A Bonačić Marinović; Hendrik Jan Hamstra; Danielle Hijdra; Lapo Mughini Gras; Inonge van Twillert; Ilse Jongerius; Cecile A C M van Els; Elena Pinelli
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

8.  Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection -is plasma exchange or eculizumab use necessary?

Authors:  Ken Saida; Masao Ogura; Yuji Kano; Shingo Ishimori; Takahisa Yoshikawa; Hiroko Nagata; Mai Sato; Koichi Kamei; Kenji Ishikura
Journal:  BMC Nephrol       Date:  2018-12-17       Impact factor: 2.388

9.  Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis.

Authors:  Andrea M DiVenere; Dzifa Amengor; Rui P Silva; Jory A Goldsmith; Jason S McLellan; Jennifer A Maynard
Journal:  mBio       Date:  2022-08-03       Impact factor: 7.786

10.  Severe infantile Bordetella pertussis pneumonia in monozygotic twins with a congenital C3 deficiency.

Authors:  Roel A J Kurvers; Dineke Westra; Arno F van Heijst; Twiggy L M Walk; Adilia Warris; Nicole C A J van de Kar
Journal:  Eur J Pediatr       Date:  2013-08-21       Impact factor: 3.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.